Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Fatty Liver on Antiviral Treatment in Patients With Hepatitis B

NCT06535048 is registered in ClinicalTrials.gov with Tianjin Second People's Hospital as lead sponsor.

NCT NCT06535048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06535048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Fatty Liver on Antiviral Treatment in Patients With Hepatitis B
Lead sponsor
Tianjin Second People's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2015
Completion date
August 31, 2024
Enrollment
500 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antiviral treatment, chronic hepatitis b, fatty liver disease